Drug intelligence / Profile preview

Mucinex Fast-Max Cold & Flu All-in-One

Development stage
Unknown
Lead developer
Reckitt
Modality
Small Molecules
Administration
Oral
01

Overview

Mucinex Fast-Max Cold & Flu All-in-One is a multi-symptom, over-the-counter combination medication developed and marketed by Reckitt. This maximum-strength formulation is designed to address nine common cold and flu symptoms through the synergistic action of four active ingredients: acetaminophen (analgesic/antipyretic), dextromethorphan HBr (antitussive), phenylephrine HCl (nasal decongestant), and guaifenesin (expectorant). It is primarily indicated for the temporary relief of cough, nasal and chest congestion, sore throat, headache, minor aches and pains, and fever. The product is typically available as an oral liquid solution and is intended for use in adults and children 12 years of age and older.

Brand names
Mucinex Cold & Flu All in OneMucinex Fast-Max Cold & Flu All-in-One
02

Targets

ADRA1A (α1A)

Beyond the preview

Go deeper on Mucinex Fast-Max Cold & Flu All-in-One.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucinex Fast-Max Cold & Flu All-in-One.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call